Norwegian Centre for Ageing and Health
Tønsberg, Vestfold, 3103, Norway
NCT Number: NCT02055092
People diagnosed with young onset dementia are today mostly assigned to the same healthcare services as people developing dementia at an older age. They and their families are however in a quite different life situation, which is likely to generate different challenges and specific needs for tailored healthcare services, of importance in maintaining their perceived quality of life.
The investigators of this study wish to assess the factors influencing these families' quality of life, their specific needs and their use of healthcare services by the use a combination of quantitative and qualitative methods. The main aim of this study is to provide better future healthcare services to these families, and to develop a programme for optimal collaboration between specialist healthcare services and the local dementia teams.
Looking for future studies?
Notify MeUp to 69 year
All sexes
Observational
Tønsberg, Vestfold, 3103, Norway
Background: Most common dementia cases in Young Onset dementia (YOD) are Alzheimer's disease (AD) and frontotemporal dementia (FTD). There is little knowledge about the impact on the affected families, especially with regard to FTD. Although their life situation and specific needs differ from that of older people, they are referred to the same healthcare services.
Hypothesis:
Methods: Nordic multicenter observational cohort study of YOD-AD and YOD-FTD. 75 persons in each group, living at home with their families, recruited from five Norwegian and four Nordic memory clinics. The control group consists of 100 older people with dementia age ≥70 years. The investigators use a combination of quantitative and qualitative methods.
The follow-up period of the persons with YOD and their family members is two years. Assessments are made at baseline, 12 and 24 months, with telephone check-ups at 6 and 18 months. The main assessment questionnaires are Quality of life in Alzheimer's disease (QoL-AD), Camberwell Assessment of Need in the Elderly (CANE), and Resource Utilization in Dementia Lite (RUD Lite).
Study aims for the quantitative part of the study:
Study aims and methods for the qualitative part of the study:
Results: Inclusion starts Feb 2014. The objective of this study is to ensure optimally tailored service provision and future healthcare planning according to the specific needs of families of YOD, and develop a care programme in collaboration between primary and specialist healthcare services.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).
Time frame: Baseline, 12 months
Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).
Time frame: Baseline, 24 months
Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).
Time frame: Baseline
Assessments by Camberwell Assessment of Need in the Elderly (CANE); 24 items for index person and 2 items for family member needs.
Time frame: Baseline
Assessments by Resource utilization in dementia Lite (RUD Lite).
Time frame: Baseline
Assessments standardized by the National Registry of Dementia: Mini Mental Status-Norwegian revision (MMSE-NR), Clock drawing Test, Trail making test part A and B, 10-word list memory recall and recognition test, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) visuospatial figure copying, FAS, Boston Naming Test, Informant questionnaire-on Cognitive decline in Dementia (IQ-CODE).
Time frame: Baseline
Assessments by Neuropsychiatric Inventory- Questionnaire (NPI-Q).
Time frame: Baseline
Assessments by Lawton & Brody I-ADL and Physical Self-maintenance Scale (PSMS).
Time frame: Baseline
Assessments by Relative's Stress Scale (RSS).
Time frame: 12 months
Assessments by Camberwell Assessment of Need in the Elderly (CANE); 24 items for index person and 2 items for family member needs.
Time frame: 24 months
Assessments by Camberwell Assessment of Need in the Elderly (CANE); 24 items for index person and 2 items for family member needs.
Time frame: 12 months
Assessments by Resource utilization in dementia Lite (RUD Lite).
Time frame: 24 months
Assessments by Resource utilization in dementia Lite (RUD Lite).
Time frame: 12 months
Assessments standardized by the National Registry of Dementia: Mini Mental Status-Norwegian revision (MMSE-NR), Clock drawing Test, Trail making test part A and B, 10-word list memory recall and recognition test, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) visuospatial figure copying, FAS, Boston Naming Test, Informant questionnaire-on Cognitive decline in Dementia (IQ-CODE).
Time frame: 24 months
Assessments standardized by the National Registry of Dementia: Mini Mental Status-Norwegian revision (MMSE-NR), Clock drawing Test, Trail making test part A and B, 10-word list memory recall and recognition test, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) visuospatial figure copying, FAS, Boston Naming Test, Informant questionnaire-on Cognitive decline in Dementia (IQ-CODE).
Time frame: 12 months
Assessments by Neuropsychiatric Inventory- Questionnaire (NPI-Q).
Time frame: 24 months
Assessments by Neuropsychiatric Inventory- Questionnaire (NPI-Q).
Time frame: 12 months
Assessments by Lawton & Brody I-ADL and Physical Self-maintenance Scale (PSMS).
Time frame: 12 months
Assessments by Relative's Stress Scale (RSS).
Time frame: 24 months
Assessments by Lawton & Brody I-ADL and Physical Self-maintenance Scale (PSMS).
Time frame: 24 months
Assessments by Relative's Stress Scale (RSS).
Time frame: Baseline
Assessments by Clinical dementia rating scale (CDR) .
Time frame: Baseline
Assessments by REED scale.
Time frame: Baseline
Assessments by Cornell Scale for Depression in Dementia (CSDD) by proxy, and using Geriatric Depression Scale (GDS) and Montgomery-Asberg Depression Rating Scale (MADRS) in family member.
Time frame: Baseline
Assessments by Locus, 17 item, for index person and family member.
Time frame: 6 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: Baseline
Time frame: 6 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: 6 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: 6 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: Baseline
Whole blood collected at baseline, analysis may be performed at a later stage (stored in research bio bank).
Time frame: 12 months
Assessments by Clinical dementia rating scale (CDR) .
Time frame: 24 months
Assessments by Clinical dementia rating scale (CDR) .
Time frame: 12 months
Assessments by REED scale.
Time frame: 24 months
Assessments by REED scale.
Time frame: 12 months
Assessments by Cornell Scale for Depression in Dementia (CSDD) by proxy, and using Geriatric Depression Scale (GDS) and Montgomery-Asberg Depression Rating Scale (MADRS) in family member.
Time frame: 24 months
Assessments by Cornell Scale for Depression in Dementia (CSDD) by proxy, and using Geriatric Depression Scale (GDS) and Montgomery-Asberg Depression Rating Scale (MADRS) in family member.
Time frame: 12 months
Assessments by Locus, 17 item, for index person and family member.
Time frame: 24 months
Assessments by Locus, 17 item, for index person and family member.
Time frame: 18 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: 12 months
Time frame: 24 months
Time frame: 6 months
Time frame: 18 months
Time frame: 18 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: 18 months
Assessments by telephone follow-up interview with index person and family member.
Time frame: 18 months
Assessments by telephone follow-up interview with index person and family member.
Norwegian Centre for Ageing and Health
Other
A Nordic Multicentre Observational Study of Persons With Young Onset Dementia and Their Families - Factors Influencing Quality of Life, Theirs Specific Needs and the Use of Healthcare Resources
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05642351
Alzheimer Disease, Brain Diseases
Nantes, France
View Trial DetailsNCT06354933
Alzheimer Disease, Basal Ganglia Diseases
Monza, Lombardy, Italy
View Trial DetailsNCT05012410
Alzheimer Disease, Arterial Occlusive Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04165213
Alzheimer Disease, Arterial Occlusive Diseases
Philadelphia, Pennsylvania, United States
View Trial Details